Published in Br J Psychiatry on April 01, 1990
Follow up of patients presenting with fatigue to an infectious diseases clinic. BMJ (1992) 3.24
The epidemiology of fatigue: more questions than answers. J Epidemiol Community Health (1992) 2.93
Longitudinal study of outcome of chronic fatigue syndrome. BMJ (1994) 2.73
Tired, weak, or in need of rest: fatigue among general practice attenders. BMJ (1990) 2.70
Frequency of attendance in general practice and symptoms before development of chronic fatigue syndrome: a case-control study. Br J Gen Pract (2001) 2.36
Chronic fatigue syndrome. Br J Psychiatry (1991) 1.99
Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress (2009) 1.61
"Abnormal" illness behaviour in chronic fatigue syndrome and multiple sclerosis. BMJ (1995) 1.37
Chronic debilitating fatigue in Irish general practice: a survey of general practitioners' experience. Br J Gen Pract (1997) 1.34
Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clin Exp Immunol (1992) 1.01
The relationship between serum trace element levels and clinical parameters in patients with fibromyalgia. Rheumatol Int (2008) 0.95
Analysis of neuropsychological functioning in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry (1993) 0.94
EEG spectral coherence data distinguish chronic fatigue syndrome patients from healthy controls and depressed patients--a case control study. BMC Neurol (2011) 0.93
Fatigue, depression, and social adjustment in chronic fatigue syndrome. Arch Dis Child (1993) 0.92
Cognitive impairment in patients with chronic fatigue: a preliminary study. J Neurol Neurosurg Psychiatry (1993) 0.90
The prognosis after multidisciplinary treatment for patients with postinfectious chronic fatigue syndrome and noninfectious chronic fatigue syndrome. J Behav Med (2002) 0.81
Illness behaviour in elite middle and long distance runners. Br J Sports Med (1999) 0.78
Gray matter volumes in patients with chronic fatigue syndrome. Evid Based Complement Alternat Med (2015) 0.77
A Brief Historic Overview of Clinical Disorders Associated with Tryptophan: The Relevance to Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM). Int J Tryptophan Res (2012) 0.77
Chronic fatigue syndrome. Br J Psychiatry (1990) 0.75
Conversation piece. Interview by P. D. Welsby. Postgrad Med J (1992) 0.75
Monospot and VP1 tests in chronic fatigue syndrome and major depression. J R Soc Med (1992) 0.75
Tularemia as a biological weapon: medical and public health management. JAMA (2001) 13.23
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res (2011) 9.24
Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.96
Inheritance of functional foreign genes in plants. Science (1984) 7.20
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.06
Controlled trial of three different antismoking interventions in general practice. Br Med J (Clin Res Ed) (1984) 6.25
Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am J Med (1993) 4.41
A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. Am J Med (1990) 3.42
Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut (2003) 3.30
Intra-aneurysmal thrombosis as a possible cause of delayed aneurysm rupture after flow-diversion treatment. AJNR Am J Neuroradiol (2010) 3.03
Longitudinal study of outcome of chronic fatigue syndrome. BMJ (1994) 2.73
Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C. Clin Infect Dis (2009) 2.68
Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust (1990) 2.17
What is myalgic encephalomyelitis? Lancet (1988) 2.17
Eosinophilia-myalgia syndrome associated with L-tryptophan use. Med J Aust (1990) 2.03
Monoclonal gammopathy: benign or not? Aust N Z J Med (1999) 2.03
The clinical features of bipolar depression: a comparison with matched major depressive disorder patients. J Clin Psychiatry (2001) 1.97
Randomised controlled trial of effectiveness of Leicester hospital at home scheme compared with hospital care. BMJ (1999) 1.97
Immunological abnormalities in the chronic fatigue syndrome. Med J Aust (1989) 1.95
CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J Virol (1998) 1.85
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Respiration (2011) 1.78
The MCP silencer of the Drosophila Abd-B gene requires both Pleiohomeotic and GAGA factor for the maintenance of repression. Development (2001) 1.74
Development of guidelines to facilitate improved support of South Asian carers by primary health care teams. Qual Health Care (2001) 1.72
The Parental Bonding Instrument. A decade of research. Soc Psychiatry Psychiatr Epidemiol (1990) 1.63
Economic evaluation of hospital at home versus hospital care: cost minimisation analysis of data from randomised controlled trial. BMJ (1999) 1.62
Generation of asymmetry during development. Segregation of type-specific proteins in Caulobacter. J Cell Biol (1979) 1.62
Iowa's National Laboratory for the study of Rural Telemedicine: a description of a work in progress. Bull Med Libr Assoc (1995) 1.62
Experiments on hydraulic jumps in turbidity currents near a canyon-fan transition. Science (1989) 1.61
Prolonged fatigue, anxiety and depression: exploring relationships in a primary care sample. Aust N Z J Psychiatry (1999) 1.58
The life skills profile: a measure assessing function and disability in schizophrenia. Schizophr Bull (1989) 1.57
Prediction of ECT response: validation of a refined sign-based (CORE) system for defining melancholia. Br J Psychiatry (1996) 1.56
The pathogenesis of pterygia. Curr Opin Ophthalmol (1999) 1.55
Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br J Ophthalmol (2006) 1.53
Parental characteristics in relation to depressive disorders. Br J Psychiatry (1979) 1.53
Reliability of long-term recall of participation in physical activity by middle-aged men and women. Am J Epidemiol (1991) 1.51
Molecular definition of the morphogenetic and regulatory functions and the cis-regulatory elements of the Drosophila Abd-B homeotic gene. Development (1991) 1.51
What is chronic fatigue syndrome? Heterogeneity within an international multicentre study. Aust N Z J Psychiatry (2001) 1.51
Reliability and sensitivity of joint space measurements in hand radiographs using computerized image analysis. J Rheumatol (2001) 1.49
Continuity and change in medical care for young adults with disabilities. J R Coll Physicians Lond (1987) 1.48
Tracing the fate of limbal epithelial progenitor cells in the murine cornea. Stem Cells (2015) 1.45
Beliefs about outcomes for mental disorders: a comparative study of primary health practitioners and psychiatrists in Singapore. Singapore Med J (2000) 1.45
A role for ectophosphatase in xenobiotic resistance. Plant Cell (2000) 1.44
Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder. Psychiatry Res (1996) 1.43
Effect of physiotherapy on sickness absence in industry: a comparative study. J Soc Occup Med (1991) 1.43
Respiratory symptoms and wheat flour exposure: a study of flour millers. Occup Med (Lond) (2000) 1.42
Personality as a vulnerability factor to depression. Br J Psychiatry (1991) 1.41
Chronic fatigue syndrome: current perspectives on evaluation and management. Med J Aust (1995) 1.41
p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours. Oncogene (1998) 1.41
Treatment of refractory neurosarcoidosis with TNF-inhibitors: what lies ahead? Intern Med J (2012) 1.40
Dural arteriovenous fistula in association with heterotopic brain nodule in the transverse sinus. AJNR Am J Neuroradiol (1998) 1.40
Development of a scale to measure interpersonal sensitivity. Aust N Z J Psychiatry (1989) 1.40
Neural network subtyping of depression. Aust N Z J Psychiatry (1998) 1.39
The role of alpha 1-antitrypsin deficiency in the pathogenesis of immune disorders. Clin Immunol Immunopathol (1985) 1.39
Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging. Eur Radiol (2012) 1.38
Red blood cell morphology in chronic fatigue syndrome. Lancet (1989) 1.38
'New' and 'old' antidepressants: all equal in the eyes of the lore? Br J Psychiatry (2001) 1.38
Multiple dose pharmacokinetics of ketoconazole and their effects on antipyrine kinetics in man. J Antimicrob Chemother (1983) 1.34
Reassessment of selective agars and filtration techniques for isolation of Campylobacter species from faeces. Eur J Clin Microbiol Infect Dis (1988) 1.34
Chemokines in acute anterior uveitis. Curr Eye Res (1997) 1.34
A systematic review of discharge arrangements for older people. Health Technol Assess (2002) 1.33
Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C. Clin Infect Dis (2011) 1.32
Cloning of developmentally regulated flagellin genes from Caulobacter crescentus via immunoprecipitation of polyribosomes. Proc Natl Acad Sci U S A (1982) 1.31
Regulation of T lymphocyte trafficking into lymph nodes during an immune response by the chemokines macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta. J Immunol (1998) 1.30
Long-term persistence of Coxiella burnetii in the host after primary Q fever. Epidemiol Infect (2000) 1.29
Parental 'affectionless control' as an antecedent to adult depression. A risk factor delineated. Arch Gen Psychiatry (1983) 1.28
Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions. Oncogene (1999) 1.26
Possible determinants, correlates and consequences of high levels of anxiety in primiparous mothers. Psychol Med (1986) 1.26
Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C. J Virol (2001) 1.25
Heterologous myb genes distinct from GL1 enhance trichome production when overexpressed in Nicotiana tabacum. Development (1999) 1.25
Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med (2004) 1.24
Seasonal variation in depressive disorders and suicidal deaths in New South Wales. Br J Psychiatry (1982) 1.24
Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression. Am J Psychiatry (1999) 1.23
Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. EMBO J (1995) 1.23
A study of client-focused case management and consumer advocacy: the Community and Consumer Service Project. Aust N Z J Psychiatry (1999) 1.22
The role of cytokines in the pathogenesis of inflammatory eye disease. Cytokine (1992) 1.22
Apyrase functions in plant phosphate nutrition and mobilizes phosphate from extracellular ATP. Plant Physiol (1999) 1.21
Differential expression of matrix metalloproteinases and their tissue inhibitors at the advancing pterygium head. Invest Ophthalmol Vis Sci (2000) 1.21
Cognitive function in depression: a distinct pattern of frontal impairment in melancholia? Psychol Med (1999) 1.20
Cranial venous outflow obstruction and pseudotumor Cerebri syndrome. Adv Tech Stand Neurosurg (2005) 1.18
Depression in general practice attenders. "Caseness", natural history and predictors of outcome. J Affect Disord (1986) 1.18
Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci (2000) 1.17
Isolation of Campylobacter: what are we missing? J Clin Pathol (1987) 1.16
The measurement of chronic pain and health-related quality of life following inguinal hernia repair: a review of the literature. Hernia (2008) 1.16
Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol (2007) 1.15
Fluorescein dilaurate--tubeless test for pancreatic exocrine failure. Lancet (1982) 1.14
Can the chronic fatigue syndrome be defined by distinct clinical features? Psychol Med (1995) 1.13
Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma. Leukemia (2004) 1.13